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Abstract. Rabies control programs, including extensive vaccination with attenuated or inactivated vaccines. However, 
such vaccines are not without problems and can have detrimental effects. Indeed attenuated vaccines can revert to a 
more virulent form, and inactivated vaccines may produce serious side effects. These facts, have led to the creation of a 
new generation of vaccines: recombinant-DNA vaccines, synthetic peptide vaccines, and anti-idiotypic vaccines. The aim 
of this study is to study the result of anti-idiotypic immunization methods in dogs detected by using enzyme linked 
immunosorbent assay (ELISA). Anti-idiotype antibodies against rabies (Ab2) were isolated from chicken blood, separated 
by means of ammonium sulfate precipitation, then dialyzed using PBS pH 8.0 for 24 hours at 2 – 8 oC and purified using 
affinity chromatography column. Three groups of dogs were immunized, group I was immunized intramuscularly (i.m) 
with purified IgY, group II was immunizded oraly (p.o) with purified IgY and group III was immunized intramuscularly 
(i.m) with rabies viral vaccines.  The antibody response (Ab3) was detected using Agar Gel Precipitation Test (AGPT). The 
efficacy of Ab3 was detected using ELISA. By ELISA, the result of immunization indicated that the level of Ab3 titers of 
anti-idiotypic vaccine immunized dogs intramuscularly are more than 0.5 IU/ml (protective according to WHO standard), 
and significantly higher than oraly immunization, but it significantly lower than Ab3 titers of rabies viral vaccine 
immunized dogs. The conclusion of this study is intramuscularly immunization of anti-idiotypic antibodies can induce 
protective immune response against rabies virus, although its lower than antibodies titer of viral vaccine, it has a good 
prospect for vaccine development in controlling rabies.  
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Introduction 
Rabies is a zoonotic viral disease which infects domestic and wild animals. Once symptoms 
of the disease develop, rabies is fatal to both animals and humans.  Humans typically contract 
the disease when bitten by infected domestic or wild animals. Rabies control programs, including 
extensive vaccination with attenuated or inactivated vaccines. However, such vaccines are not 
without problems and can have detrimental effects. Indeed attenuated vaccines can revert to a 
more virulent form, and inactivated vaccines may produce serious side effects. These facts, have 
led to the creation of a new generation of vaccines: recombinant-DNA vaccines, synthetic 
peptide vaccines, and anti-idiotypic vaccines. 
The idiotype of an immunogiobulin molecule is formed by the total set of idiotopes, i.e., 
antigenic determinants on the variable region of an immunoglobulin molecule which are 
recognized by anti-idiotypic antibodies.The specific part of the variable region that binds to the 
antigen is referred to as the paratope. Jerne originally proposed that a series of idiotypic-anti-
idiotypic interactions regulate the immune response to an antigen. Interaction between idiotypes 
of both antibody molecules and lymphocyte antigen receptors may form an idiotypic network in 
which a state of dynamic equilibrium exists. Administration of antigen disturbs this equilibrium 
and evokes an immune response. Antibody (Ab1) will be produced in response to this external 
stimulus. Since antibody molecules bear immunogenic idiotopes and because of the diversity and 
completeness of the antibody repertoire, anti-idiotopic antibody (Ab2) will be formed. Many 
reports have been published supporting this concept that idiotypes may function as targets of 
regulatory sign of idiotopes, i.e., antigenic determinants on the variable region of an 
immunoglobulin molecule which are recognized by anti-idiotypic antibodies (Ban et al. 1994). 
Anti-idiotype antibody can induce protective immune response against rabies virus and can 
be used as an alternative for rabies anti-idiotype vaccine. Efficacy of Ab3 was detected using 
enzyme linked immunosorbent assay (ELISA) indicated that the level of Ab3 titer is protective 
according to WHO standard (more than 0.5 IU/ml) (Paryati, 2009). For the application of anti-
idiotypic vaccine, its required to test of potency vaccine on animal laboratorium. The aim of this 
study to evaluate potency of rabies anti-idiotypic (Ab2) for their immunogenecity and protection. 
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Materials and Methods 
Polyclonal anti-idiotype (anti-Id) antibodies were prepared in laying chickens against anti 
rabies serum (ARS), called antibody 1 (Ab1). ARS was used as the antigen to immunize laying 
chickens. Anti-Ab1 chicken immunoglobulins (IgY), the anti-idiotype antibodies against rabies 
(Ab2) was isolated from chicken blood every week for ten weeks. Immunoglobulin Y was 
separated by means of ammonium sulfate precipitation, then dialyzed using PBS pH 8.0 for 24 
hours at 2 – 8 oC and purified using affinity chromatography column for IgY.   
Potency test were done on animal model. Three groups of dogs were immunized, group I 
was immunized intramuscularly (i.m) with purified IgY, group II was immunizded oraly (p.o) 
with purified IgY and group III was immunized intramuscularly (i.m) with rabies viral vaccines.  
Immunization were done at 0, 7th and 14th day (WHO, 2002).  The antibody response (Ab3) was 
detected before immunization and then at 2, 4, after , 12 and 16 week pasca immunization 
using Agar Gel Precipitation Test (AGPT). The efficacy of Ab3 was detected using enzyme linked 
immunosorbent assay (ELISA). 
 
Results and Discussion 
Anti-idiotypic Immunoglobulin 
Two weeks after last immunization, chicken sera harvested from chicken immunized, and 
tested with AGPT showed the positive reaction signed by precipitation line among serum and 
ARS (Fig. 1). This indicated that chicken can produce antibodies that induced by ARS.  The 
highest titer of Ab2s was found at the third week after the last immunization (Fig. 3). According 
to the Jerne hypothesis, the immune system responds to foreign substances as a regulatory 
networks composed of idiotypes (Ab1s) and their anti-idiotypes (Ab2s). The antibodies Ab1s 
made in response to the original antigen becomes itself an antigen and elicits the synthesis of a 
secondary antibodies, or Ab2s. This response can be divided into an antigen-noninhibitable group 
(Ab2α) and an antigen-inhitable group (Ab2β). A third group, which is antigen inhitable because 
of steric hindrance with antigen binding site, is designated Ab2γ.  
Idiotypes are the some of idiotopes or serologically 
determined antigenic determinants unique to an 
antibody or group of antibodies. Ab2s produced 
against the combining-site idiotope may carry an 
internal immage of the external antigen and are also 
known as internal-immage antidodies. A true 
internal-immage molecule can induce immune-
mediated responses similar to induced by original 
antigen, and this property has, in fact, been used to 
produce vaccines. Thus they may be significant 
structural mimicry between the complementarity-
determining regions (CDRs) of internal immage Ab2s 
and this original antigen (Ban et al. 1994).  
In addition to their presence as circulating 
molecules, immunoglobulins are found on the surface 
of B cells, and immunoglobulin-like structures 
comprise the T-cell receptor for antigen. All these 
molecules bear idiotypes. Thus, idiotype-antiidiotype 
interactions will involve antibody-cell and cell-cell 
interactions as well as antibody-antibody interactions. It is by involving cell regulation that the 
potential for suppression or enhancement of antibody production may occur. The precise 
mechanisms by which idiotype-antiidiotype interactions help regulate the immune response are 
not known. Initial studies merely examined antibody-B-cell interactions, but recent advances in 
the understanding of T-cell receptor structure and function has focused attention on reports of 
induction of idiotype-specific 'suppressor' and cytotoxic T cells (Shoenfeld 2004; Nisonoff 1991). 
Purification of Immunoglobulin 
Protein purification using affinity chromatography column for IgY than characterized using 
Sodium Dodecyl Polyacrylamide Gel Electrophoresis (SDS-PAGE), lead the proteins molecules 
with 185,000; 95,000 and 49,000 dalton in weigth, and this result same with the weight of IgY, 
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 serum  
Fig. 1. Positive reaction with AGPT 
showed by precipitation line (arrow) 
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is about 180,000 dalton. The antibody response (Ab3s) was detected using Agar Gel Precipitation 
Test (AGPT) showed specific reaction with Ab2 as well as rabies virus. Interestingly, Ab2 and 
rabies virus express partial identity reaction. This lead the insight, that not all parts of Ab2s are 
internal image of rabies virus. In 1978, Kohler proposed a new function of antibodies in the 
regulation of immune responses. Antibodies have specific variable sequence determinants which 
are detected by anti-idiotypic antisera. Anti-idiotypic antibodies can suppress the production of 
the complementary idiotypic antibody and are, therefore, specific anti-receptor antibodies. 
Experiments in inbred mice have shown that mutual and reciprocal functional interactions of 
idiotype and anti-idiotype can occur. These findings give evidence for regulatory mechanisms in 
the expressions of immune clones by complementary idiotypes. An idiotype actually consists of 
multiple antigenic determinants, each of which is an idiotope. The antigenic determinants or 
idiotopes can reside in the heavy chain component of the V region, in its light chain component, 
or they may consist of a surface made up of parts of both chains. The idiotype of an antibody is, 
therefore, a way to describe by serological means the variable region of an antibody molecule. 
Originally, idiotypes were defined by heterologous antisera made, for example, by immunizing a 
rabbit with a monoclonal human myeloma protein. After extensive absorption with normal 
human immunoglobulins, such antisera were found to bind only to the V region of the 
immunizing myeloma immunoglobulin. Thus, idiotypes were originally thought to be unique 
markers of individual antibodies (hence their name). However, it is now known that different 
antibodies can share the same, or similar, idiotype. Even antibodies with different antigen-
binding specificities can share the same idiotype if they use the same heavy or light chain in 
forming their V regions. Such antibodies constitute parallel sets. Thus, idiotypes can be: private 
(confined to a particular immunoglobulin molecule), public (shared by different antibodies), or 
cross-reactive (different idiotypes containing similar antigenic structures) (Migliorini and 
Schwartz 1988). 
Potency Test 
The efficacy of Ab3s detected using enzyme linked immunosorbent assay (ELISA) 
indicated that the level of Ab3s titer is protective according to WHO standard (more than 0.5 
IU/ml). Anti-idiotype antibody can induce protective immune response against rabies virus and 
can be used as an alternative for rabies anti-idiotype vaccine (Paryati et al. 2006). These 
findings indicate that Ab2 induced the formation of antigen-specific Ab3, probably because it 
bears the internal image of the rabies virus. This Ab2 may therefore have potential for 
modulating the immune response (Herlyn 1986). 
Table 1. Means of rabies antibodies titer 
 
Group 
 
Rabies antibody titer of dog pasca immunization (IU/ml) 
Pre-
immunization 
week 
2 4 8 12 16 
p.o. (IgY) 0,05 0,11 0,10 0,22 0,35 0,26 
S.c. (IgY) 0,15 0,20 0,30 0,52 * 0,59 * 0,52 * 
S.c (rab) 0,09 0,47 0,96 * 1,03 * 0,82 * 0,57 * 
Remarks:  
• p.o (IgY)   :  immunization with crude immunoglobulin per oral  
• s.c (IgY)    : immunization with purified immunoglobulin (IgY) subcutaneous  
• S.c (rab)   : immunization with commercial rabies vaccine subcutaneous   
• Mark (*)   :  Protective titer antibodi of rabies (> 0,5 IU/ml) 
 
Statistical analysis (Table 1) of Ab3s titer indicated that the Ab3s titer of anti-idiotypic 
immunization per oral (p.o) were not yielded protective titers. Its might be that 
immunoglobuline Y were damaged by digestive enzymes. Antibodies titer of anti-idiotypic 
vaccine immunization (s.c) on the eigth week until 16th week post immunization were protective 
(yielded > 0,5 IU/ml of the antibodies titer) but very significantly (P<0,01) lower than the level 
antibodies induced by viral rabies vaccine on the forth until 16th week post immunization. This 
indicated that anti-idiotypic antibodies could not induce the same level of antibodies induced by 
viral vaccine. But theoretically, anti-Id antibodies may provide advantages as vaccines over 
conventional or even some recombinant DNA based vaccines, including: (1) the lack of risks 
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associated with live pathogens; (2) relatively inexpensive preparation compared to propagation 
of virus; (3) the fact that anti-Id antibodies mimic the native 3-dimensional conformation of the 
antigen and, therefore, may stimulate a better immune response than inactivated or subunit 
vaccines which may have been altered in antigenicity; and (4) the fact that some anti-Id 
antibodies have the potential to stimulate both humoral and cellular immunity. 
 
Fig. 2. Graphic of antibodies titer harvested from immunized dog 
Conversion of OD values to International Unit (IU) indicated that antibodies titer of sera 
harvested from dogs immunized with anti-idiotypic antibodies were higher than 0.5 IU at the 
fourth week until the 16th week (Fig 2). This means that anti-idiotypic antibodies can induce 
protective antibodies againts rabies (according to WHO standard) (OIE 2004). This titer was 
decreased after 16 weeks p.i. 
 
Conclusions 
The conclusions of this study are (1) the anti-idiotype antibody can induce protective 
immune response against rabies virus and can be used as an alternative for rabies anti-idiotype 
vaccine, (2) the efficacy of Ab3s was detected using enzyme linked immunosorbent assay 
(ELISA) and indicated that the level of Ab3 titer is protective according to WHO standard (more 
than 0.5 IU/ml), (3) statistical analysis of Ab3s titer indicated that the Ab3s titer of anti-idiotypic 
immunization were protective started from 4th until 16th pasca immunization, significantly higher 
on the 8th until 16th week post immunization compared with control serum (P<0.05) but 
significantly (P<0,01) lower than the level antibodies induced by viral rabies vaccine on the four 
until 16th weeks post immunization, (4) this titer was decreased after 16th weeks post 
immunization 
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